1
|
Wei X, Zhang HC, Tu YH, Li X, Wu WS. Interventional chemoembolization for the treatment of severe ulcerative bleeding caused by advanced breast cancer: A report of two cases. Exp Ther Med 2024; 27:36. [PMID: 38125357 PMCID: PMC10731400 DOI: 10.3892/etm.2023.12324] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2023] [Accepted: 09/01/2023] [Indexed: 12/23/2023] Open
Abstract
Local ulcerative cutaneous hemorrhage resulting from breast cancer profoundly effects the quality of life of patients, at times even posing a threat to life. While early diagnosis rates of breast cancer have shown improvement, some patients may present at an advanced stage upon consultation. Presently, there is no standardized treatment approach for these patients. In this context, the present study presented two case studies detailing the use of interventional embolization chemotherapy for addressing severe local ulcerative hemorrhage associated with breast cancer. Post-treatment, there was a notable amelioration in the mammary ulceration among the patients, an elevated hemoglobin level compared with baseline and a consequent enhancement in their overall quality of life. These cases may serve as valuable references for the management of such clinical situations.
Collapse
Affiliation(s)
- Xing Wei
- Emergency Department, The Affiliated Traditional Chinese Medicine Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510130, P.R. China
| | - Hong-Chao Zhang
- Department of Acupuncture and Rehabilitation, Guangzhou Yuexiu Orthopedics and Traumatology Rehabilitation Hospital, Guangzhou, Guangdong 510199, P.R. China
| | - Yue-He Tu
- Fifth Department of Oncology, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510168, P.R. China
| | - Xiang Li
- Fifth Department of Oncology, Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong 510168, P.R. China
| | - Wei-Sheng Wu
- Medical Clinic, The Affiliated Traditional Chinese Medicine Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510130, P.R. China
| |
Collapse
|
2
|
Saiga A, Aramaki T, Sato R, Iwai K. A Case of Bilateral Internal Mammary Arterial Infusion Chemotherapy Using Implantable Port-catheter Systems for Anterior Chest Wall Metastasis of Breast Cancer. INTERVENTIONAL RADIOLOGY (HIGASHIMATSUYAMA-SHI (JAPAN) 2023; 8:14-17. [PMID: 36936256 PMCID: PMC10017271 DOI: 10.22575/interventionalradiology.2022-0018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 05/21/2022] [Accepted: 10/11/2022] [Indexed: 02/10/2023]
Abstract
The patient was a 53-year-old woman who presented with a metastatic tumor of the anterior chest wall after chemotherapy for right accessory breast cancer and radiation therapy for right axillary lymphadenopathy. She had already received standard treatment, but the metastatic tumor was uncontrollable and exacerbated. Palliative treatment by arterial infusion chemotherapy with an implantable catheter-port system was planned. We indwelled a port system through the arteries because the bilateral internal mammary arteries presented a dominant blood supply. The metastatic tumor almost disappeared by arterial infusion chemotherapy after 3 months. This method may be effective in selected cases of arterial infusion chemotherapy for breast cancer.
Collapse
Affiliation(s)
- Atsushi Saiga
- Division of Interventional Radiology, Shizuoka Cancer Center, Japan
| | - Takeshi Aramaki
- Division of Interventional Radiology, Shizuoka Cancer Center, Japan
| | - Rui Sato
- Division of Interventional Radiology, Shizuoka Cancer Center, Japan
| | - Kenji Iwai
- Division of Interventional Radiology, Shizuoka Cancer Center, Japan
| |
Collapse
|
3
|
Ma J, Song J, Chen H, Fan C, Xie J, Qi X. Intra-arterial interventional therapy for inoperable local advanced breast cancer: A retrospective study. Oncol Lett 2018; 15:1955-1962. [PMID: 29434896 DOI: 10.3892/ol.2017.7507] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/22/2016] [Accepted: 10/13/2017] [Indexed: 11/06/2022] Open
Abstract
The aim of the present study was to evaluate the safety and efficacy of intra-arterial interventional therapy (IAIT) in the treatment of inoperable local advanced breast cancer (LABC). A total of 7 patients with pathologically proven inoperable LABC were included in the present study. Patients received 1-4 cycles of IAIT prior to mastectomy and postoperative adjuvant therapy. The safety and clinical outcomes of IAIT were retrospectively analyzed. Between February 2009 to September 2016, 7 patients received IAIT. The youngest patient was 34 years old and the eldest was 90 years old. The tumor size ranged between 6 and 20 cm in diameter. A total of 5 patients presented with palpable lymph nodes, while none of the patients exhibited distant metastatic disease. A total of 6 patients received ≥1 cycle of neoadjuvant chemotherapy prior to IAIT and no severe side effects were observed. Overall, 6 patients exhibited a partial response and 1 presented with stable disease following treatment. The range of progression-free survival was 6-88 months. In total, 1 patient succumbed as a result of another disease 8 months after IAIT, another succumbed from carcinoma of the right fallopian tube and multiple organ metastases 9 months after IAIT, and another survived for 11 months and died of heart disease after IAIT. The other 4 patients remain alive. IAIT is safe and effective for patients with inoperable LABC, and thus, may be an appropriate alternative for patients who are not responsive to or are unable to tolerate neoadjuvant chemotherapy.
Collapse
Affiliation(s)
- Jing Ma
- Department of Breast Surgery, People's Liberation Army General Hospital, Beijing 100700, P.R. China
| | - Jin Song
- Department of Breast Surgery, People's Liberation Army General Hospital, Beijing 100700, P.R. China
| | - Hai Chen
- Department of Breast Surgery, People's Liberation Army General Hospital, Beijing 100700, P.R. China
| | - Cibo Fan
- Department of Breast Surgery, People's Liberation Army General Hospital, Beijing 100700, P.R. China
| | - Jiaqi Xie
- Department of Breast Surgery, People's Liberation Army General Hospital, Beijing 100700, P.R. China
| | - Xiaodong Qi
- Department of Breast Surgery, People's Liberation Army General Hospital, Beijing 100700, P.R. China
| |
Collapse
|
4
|
Kennoki N, Hori S, Hori A, Takeo Y, Oshiro H. Transcatheter arterial chemoembolization with spherical embolic material for locally advanced breast cancer: first report of HepaSphere™ treatment for primary breast cancer. BJR Case Rep 2016; 2:20150417. [PMID: 30460025 PMCID: PMC6243306 DOI: 10.1259/bjrcr.20150417] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/22/2015] [Accepted: 05/26/2016] [Indexed: 11/05/2022] Open
Abstract
A 57-year-old female was diagnosed as having primary breast cancer (invasive carcinoma of no special type), which was immunohistochemically negative for oestrogen receptor, androgen receptor and human epidermal growth factor receptor Type 2. The main tumour was 54 × 35 mm in size and was located in the internal upper area of the left breast. The tumour had markedly invaded the skin and a daughter nodule was observed in the external upper area of the ipsilateral breast. An enlarged lymph node measuring 12mm in diameter was present in the axilla and an affected parasternal lymph node was also observed. A blood test showed no abnormalities and the patient was negative for tumour markers. We performed three sessions of transcatheter arterial chemoembolization with docetaxel-loaded HepaSphere™. The treatment procedure was successfully performed in all the three sessions. No adverse events higher than Grade 3 were observed. The sizes of the primary lesion and axillary lymph node decreased to 26 × 14 mm (37% reduction) and 10mm, respectively. The parasternal lymph node completely resolved. 2 months later, left total mastectomy and axillary lymph node dissection were performed. The histopathological post-therapy effect was considered to be a mild response (Grade 1a) in the breast lesion and a complete response (Grade 3) in the axillary lymph node. The mean±standard deviation of the minor axis of the vessels embolized with spherical particles was 183.0±96.5 μm. Our results indicate that transcatheter arterial chemoembolization used together with HepaSphere can be an alternative and effective therapy for locally advanced breast cancer.
Collapse
Affiliation(s)
- Norifumi Kennoki
- Department of Radiology, Tokyo Medical University Hachioji Medical Center, Tokyo, Japan
| | - Shinichi Hori
- Department of Radiology, Gate Tower Institute for Image Guided Therapy, Osaka, Japan
| | - Atsushi Hori
- Department of Radiology, Rinku Dejima Clinic, Osaka, Japan
| | - Yuki Takeo
- Department of Radiology, Gate Tower Institute for Image Guided Therapy, Osaka, Japan
| | - Hisashi Oshiro
- Department of Pathology, Tokyo Medical University Hospital, Tokyo, Japan
| |
Collapse
|
5
|
Wang X, Gan C, Li H, Wei Y, Zhu D, Yang G, Su X, Rodier JF, Ren G. Main complications and results of treatment with intra-arterial infusion chemotherapy through the subclavian and thoracic arteries for locally advanced breast cancer. Mol Clin Oncol 2013; 1:745-748. [PMID: 24649239 PMCID: PMC3915647 DOI: 10.3892/mco.2013.129] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2012] [Accepted: 04/16/2013] [Indexed: 11/06/2022] Open
Abstract
Intra-arterial infusion chemotherapy for locally advanced breast cancer (LABC) has been previously performed. However, the main complications of this type of chemotherapy remain to be clarified. In the present study, catheterization chemotherapy was carried out for 53 LABC cases (stage IIIa–IIIc) between May, 2006 and March, 2007. For IIIB and IIIC patients, the catheters were guided to the opening of the subclavian artery. For stage IIIa patients, the catheters were placed into the thoracic artery through a subcutaneous femoral artery puncture. One to four cycles of chemotherapy (mean, 1.6 cycles) were administered for the patients using taxotere, epidoxorubicin, 5-fluorouracil and/or cyclophosphamide. The interval time between the two cycles was 21 days. Seven cases were identified as complete response (CR, 13.2%), 41 cases were partial response (PR, 77.4%) with a rate of effectiveness of (CR + PR, 90.6%), 5 cases were stable disease (SD, 9.40%) and no case was progressive. Pain of the ipsilateral upper extremity was present in 7 cases. Two cases exhibited ipsilateral upper extremity atrophy following drug administration from the opening of the subclavian artery. One case experienced neck pain and headache, while in one case necrosis of local skin was evident. Hematological toxicity over grade 3 was observed in 6 cases (11.30%). Systemic toxicity was mild and did not affect the quality of life of the patients. Overall survival was identified as 18/51 (35.3%), and free-disease survival as 10/51 (19.6%). In conclusion, intra-arterial infusion chemotherapy is an effective local control treatment for LABC. The main complications are pain of the ipsilateral upper extremity and neck as well as headache. Severe complications are ipsilateral upper extremity atrophy and necrosis of local skin. During the treatment, controlling the pressure of the tourniquet and velocity of drug administration are crucial for reducing local complications.
Collapse
Affiliation(s)
- Xiaoyi Wang
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| | - Changing Gan
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| | - Hongyuan Li
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| | - Yuxian Wei
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| | - Donchang Zhu
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| | - Guanglun Yang
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| | - Xinliang Su
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| | - Jean-François Rodier
- Department of Surgical Oncology, Paul Strauss Cancer Center, 67065 Strasbourg, France
| | - Guosheng Ren
- Department of Breast and Endocrine Surgery, First Affiliated Hospital, Chongqing Medical University, Chongqing 400016, P.R. China
| |
Collapse
|
6
|
Koike Y, Takizawa K, Ogawa Y, Nakajima Y. Bilateral approach of redistributed subclavian arterial infusion chemotherapy for locally advanced breast cancer spreading to the contralateral chest wall. Acta Radiol 2012; 53:750-3. [PMID: 22919054 DOI: 10.1258/ar.2012.120074] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/18/2022]
Abstract
A catheter port system technique called redistributed subclavian arterial infusion chemotherapy (RESAIC) for locally advanced breast cancer was reported and seemed to be effective for local control and as a palliative treatment. However, when the cancer spreads beyond the medial line to the contralateral chest wall, ipsilateral RESAIC would not achieve a favorable drug distribution. We report on two patients with advanced breast cancer spreading to the contralateral chest wall in whom bilateral RESAIC was attempted. In summary, when advanced breast cancer spreads to the contralateral chest wall, bilateral RESAIC may be useful for local control or palliation.
Collapse
Affiliation(s)
- Yuya Koike
- Department of Radiology, Kawasaki Municipal Tama Hospital, Kanagawa
| | - Kenji Takizawa
- Department of Radiology, St Marianna University School of Medicine Hospital, Kanagawa, Japan
| | - Yukihisa Ogawa
- Department of Radiology, St Marianna University School of Medicine Hospital, Kanagawa, Japan
| | - Yasuo Nakajima
- Department of Radiology, St Marianna University School of Medicine Hospital, Kanagawa, Japan
| |
Collapse
|